When targeting problem proteins involved in causing or spreading disease, a drug will often clog up a protein’s active site so it can’t function and wreak havoc.
Novo Nordisk Foundation sets up airborne infection vaccine initiative
Share this article The initiative for vaccine and immunity (NIVI) will focus on designing vaccines that generate immunity in the respiratory system, said Professor Peter